Therapeutic Trial in Hereditary Angioedema Type III: Icatibant

World Allergy Organization Journal - United Kingdom
doi 10.1186/1939-4551-8-s1-a220
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Hereditary Angioedema Type 1

2020English

Management of Patients With Hereditary Angioedema in Germany: Comparison to Other Countries in the Icatibant Outcome Survey

Journal of the European Academy of Dermatology and Venereology
DermatologyInfectious Diseases
2018English

A Case of Type 2 Hereditary Angioedema WithSERPING1Mutation

Allergy, Asthma and Immunology Research
ImmunologyPulmonaryAllergyRespiratory Medicine
2017English

Icatibant in the Treatment of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema

Case Reports in Critical Care
2014English

The Hereditary Angioedema Syndromes

Journal of Clinical Investigation
Medicine
2018English

A Randomized Trial of Human C1 Inhibitor Prophylaxis in Children With Hereditary Angioedema

Pediatric Allergy and Immunology
ImmunologyChild HealthAllergyPediatricsPerinatology
2019English

Socioeconomic Burden of Hereditary Angioedema: Results From the Hereditary Angioedema Burden of Illness Study in Europe

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2014English

The Pathophysiology of Hereditary Angioedema

World Allergy Organization Journal
ImmunologyPulmonaryAllergyRespiratory Medicine
2010English

Hereditary Angioedema and Thyroid Autoimmunity.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1987English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy